Television advertisement

• US FDA says Novo's obesity pill TV Ad is false or misleading - Feb 9 (Reuters) - The U.S. Food and Drug Administration said a television advertisement for Novo Nordisk's weight-loss pill is "false or misleading", according to a letter dated February 5.